Literature DB >> 23765201

Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire.

M T Duruöz1, L Doward, Y Turan, L Cerrahoglu, M Yurtkuran, M Calis, N Tas, S Ozgocmen, O Yoleri, B Durmaz, S Oncel, T Tuncer, O Sendur, M Birtane, F Tuzun, U Bingol, M Kirnap, G Celik Erturk, O Ardicoglu, A Memis, F Atamaz, R Kizil, C Kacar, G Gurer, K Uzunca, H Sari.   

Abstract

The Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire is a disease-specific measure of needs-based quality of life developed in the UK and the Netherlands. This study describes translation, validation, and reliability of the scale into Turkish population. The ASQoL was translated into Turkish using the dual-panel process. Content validity was assessed via cognitive debriefing interviews with ankylosing spondylitis (AS) patients. Patients with AS according to modified New York criteria were recruited into the study from 12 hospitals of all part of Turkey. Psychometric and scaling properties were assessed via a two administration survey involving the ASQoL, the Nottingham Health Profile (NHP), Bath AS Functional Index (BASFI), and Bath AS Disease Activity Index (BASDAI). Classical psychometrics assessed reliability, convergent validity (correlation of ASQoL with NHP, BASFI, and BASDAI) and discriminative validity (correlation of ASQoL with perceived AS-severity and general health). Cognitive debriefing showed the new Turkish ASQoL to be clear, relevant, and comprehensive. Completed survey questionnaires were received from 277 AS patients (80% Male, mean age 42.2/SD 11.6, mean AS duration 9.4 years/SD 9.4). Test-retest reliability was excellent (0.96), indicating low random measurement error for the scale. Correlations of ASQoL with NHP sections were low to moderate (NHP Sleep 0.34; NHP Emotional Reactions 0.83) suggesting the measures assess related but distinct constructs. The measure was able to discriminate between patients based on their perceived disease severity (p < 0.0001) and self-reported general health (p < 0.0001). The Turkish version of ASQoL has good reliability and validity properties. It is practical and useful scale to assess the quality of life in AS patients in Turkish population.

Entities:  

Mesh:

Year:  2013        PMID: 23765201     DOI: 10.1007/s00296-013-2796-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  Development and validation of the French ASQoL questionnaire.

Authors:  Thao Pham; Désirée M van der Heijde; Jacques Pouchot; Francis Guillemin
Journal:  Clin Exp Rheumatol       Date:  2010-06-23       Impact factor: 4.473

2.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients.

Authors:  Ahmet Ozgül; Fatma Peker; M Ali Taskaynatan; A Kenan Tan; Kemal Dinçer; Tunç Alp Kalyon
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  The Nottingham Health Profile: subjective health status and medical consultations.

Authors:  S M Hunt; S P McKenna; J McEwen; J Williams; E Papp
Journal:  Soc Sci Med A       Date:  1981-05

6.  Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis.

Authors:  Rafael Ariza-Ariza; Blanca Hernández-Cruz; Federico Navarro-Sarabia
Journal:  Arthritis Rheum       Date:  2003-08-15

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity.

Authors:  Yesim Akkoc; Altinay Goksel Karatepe; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-01-17       Impact factor: 2.631

9.  The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Clin Rheumatol       Date:  2004-08-31       Impact factor: 2.980

10.  Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population.

Authors:  L K Zhao; Z T Liao; C H Li; T W Li; J Wu; Q Lin; F Huang; D T Yu; J R Gu
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 3.580

View more
  25 in total

1.  Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.

Authors:  Gamze Kılıç; Erkan Kılıç; Kemal Nas; Murat Karkucak; Erhan Çapkın; Abdullah Zübeyir Dağlı; Remzi Çevik; Salih Özgöçmen
Journal:  Clin Rheumatol       Date:  2014-07-02       Impact factor: 2.980

2.  Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial.

Authors:  Duygu Şilte Karamanlioğlu; Ilknur Aktas; Feyza Unlu Ozkan; Meryem Kaysin; Nuray Girgin
Journal:  Rheumatol Int       Date:  2016-02-29       Impact factor: 2.631

3.  Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life.

Authors:  Pelin Oktayoglu; Serda Em; Mehmet Tahtasiz; Mehtap Bozkurt; Demet Ucar; Levent Yazmalar; Kemal Nas; Ibrahim Yardımeden; Figen Cevik; Yusuf Celik; Nuriye Mete
Journal:  Rheumatol Int       Date:  2012-11-10       Impact factor: 2.631

4.  Is magnetotherapy applied to bilateral hips effective in ankylosing spondylitis patients? A randomized, double-blind, controlled study.

Authors:  Yasemin Turan; Kevser Bayraktar; Fatih Kahvecioglu; Engin Tastaban; Elif Aydin; Imran Kurt Omurlu; Isil Karatas Berkit
Journal:  Rheumatol Int       Date:  2014-01-08       Impact factor: 2.631

5.  Relationship of the sexual functions with the clinical parameters, radiological scores and the quality of life in male patients with ankylosing spondylitis.

Authors:  Mustafa Akif Sariyildiz; Ibrahim Batmaz; Banu Dilek; Ahmet Inanir; Yasin Bez; Mehmet Tahtasiz; Serda Em; Remzi Cevik
Journal:  Rheumatol Int       Date:  2012-04-07       Impact factor: 2.631

6.  Effects of home-based exercise intervention on health-related quality of life for patients with ankylosing spondylitis: a meta-analysis.

Authors:  Hui Liang; Hua Zhang; Haiyan Ji; Chunmei Wang
Journal:  Clin Rheumatol       Date:  2015-03-15       Impact factor: 2.980

7.  Description of the registry of patients with ankylosing spondylitis in Turkey: TRASD-IP.

Authors:  Hatice Bodur; Sebnem Ataman; Derya Soy Buğdaycı; Aylin Rezvani; Kemal Nas; Kaan Uzunca; Emel Emlakçıoğlu; Altınay Göksel Karatepe; Bekir Durmuş; Melek Sezgin; Figen Ayhan; Pelin Yazgan; Tuncay Duruöz; Mahmut Yener; Alev Gürgan; Mehmet Kırnap; Engin Cakar; Lale Altan; Raikan Soydemir; Erhan Capkın; Ibrahim Tekeoğlu; Gülümser Aydın; Zafer Günendi; Barış Nacır; Ali Sallı; Cihat Oztürk; Asuman Memiş; Yasemin Turan; Erkan Kozanoğlu; Konçuy Sivrioğlu
Journal:  Rheumatol Int       Date:  2010-08-14       Impact factor: 2.631

Review 8.  Treat-to-target in axial spondyloarthritis - what about physical function and activity?

Authors:  Jürgen Braun; Xenofon Baraliakos; Uta Kiltz
Journal:  Nat Rev Rheumatol       Date:  2021-07-26       Impact factor: 20.543

9.  Adaptation and validation of the Ankylosing Spondylitis Work Instability Scale (AS-WIS) for use in Turkey.

Authors:  Ayşe A Küçükdeveci; Şebnem Ataman; Aysun Genç; Şehim Kutlay; Atilla H Elhan; Derya Őztuna; Alan Tennant
Journal:  Rheumatol Int       Date:  2014-06-03       Impact factor: 2.631

10.  Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning.

Authors:  Ozlem Yılmaz; Ahmet Tutoğlu; Yeşim Garip; Esra Ozcan; Hatice Bodur
Journal:  Rheumatol Int       Date:  2012-09-06       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.